T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death
T315, an integrin-linked kinase (ILK) inhibitor, has been shown to suppress the proliferation of breast cancer, stomach cancer and chronic lymphocytic leukemia cells. Here we demonstrate that T315 decreases cell viability of acute myeloid leukemia (AML) cell lines (HL-60 and THP-1) and primary leuke...
Main Authors: | Chang-Fang Chiu, Jing-Ru Weng, Appaso Jadhav, Chia-Yung Wu, Aaron M. Sargeant, Li-Yuan Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/8/1337 |
Similar Items
-
Tyrosine kinase inhibitor treatment outcome in a single center cohort of chronic myeloid leukemia patients. The role of the T315I ABL kinase domain mutation
by: Dima Delia, et al.
Published: (2013-03-01) -
Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors
by: Xu PP, et al.
Published: (2017-09-01) -
Lapatinib induces autophagic cell death and differentiation in acute myeloblastic leukemia
by: Chen YJ, et al.
Published: (2016-07-01) -
Mutational analysis of T315I in patients with chronic myeloid leukemia who did not respond to second-generation tyrosine kinase inhibitors
by: Riyam Qusay Ibrahim Al-Jadir, et al.
Published: (2020-01-01) -
Blocking Autophagic Flux Enhances Matrine-Induced Apoptosis in Human Hepatoma Cells
by: Li Wang, et al.
Published: (2013-11-01)